Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells
<p>Abstract</p> <p>Background</p> <p>Cerebral palsy is currently one of the major diseases that cause severe paralysis of the nervous system in children; approximately 9–30% of cerebral palsy patients are also visually impaired, for which no effective treatment is avail...
Main Authors: | Li Min, Yu Aixue, Zhang Fangfang, Dai GuangHui, Cheng Hongbin, Wang Xiaodong, An Yihua |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/10/1/100 |
Similar Items
-
Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial
by: Liem Thanh Nguyen, et al.
Published: (2017-04-01) -
Role of XIAP gene overexpressed bone marrow mesenchymal stem cells in the treatment of cerebral injury in rats with cerebral palsy
by: Wenjing Deng, et al.
Published: (2019-10-01) -
Autologous bone marrow-derived cell transplantation in the treatment of cerebral stroke
by: A. L. Krivoshapkin, et al.
Published: (2008-12-01) -
Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy
by: Chen Guojun, et al.
Published: (2013-01-01) -
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
by: Atieh Makhlough, et al.
Published: (2017-05-01)